Pediatric Rhabdomyosarcoma.

Jack F Shern, Marielle E Yohe, Javed Khan
Author Information
  1. Jack F Shern: Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
  2. Marielle E Yohe: Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
  3. Javed Khan: Genetics Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland; Pediatric Oncology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.

Abstract

Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood, and despite clinical advances, subsets of these patients continue to suffer high levels of morbidity and mortality associated with their disease. Recent genetic and molecular characterization of these tumors using sophisticated genomics techniques, including next-generation sequencing experiments, has revealed multiple areas that can be exploited for new molecularly targeted therapies for this disease.

References

  1. Cancer Res. 1993 May 15;53(10 Suppl):2231-4 [PMID: 8387391]
  2. Front Oncol. 2013 Jul 17;3:183 [PMID: 23882450]
  3. Cancer Res. 1989 Nov 15;49(22):6324-7 [PMID: 2680062]
  4. FEBS J. 2013 Sep;280(17):4323-34 [PMID: 23822136]
  5. J Clin Invest. 2009 Nov;119(11):3395-407 [PMID: 19809159]
  6. J Clin Oncol. 2007 Feb 1;25(4):362-9 [PMID: 17264331]
  7. Genes Chromosomes Cancer. 2000 Jun;28(2):220-6 [PMID: 10825007]
  8. Genes Chromosomes Cancer. 2010 Mar;49(3):224-36 [PMID: 19953635]
  9. Nat Rev Cancer. 2011 Oct 13;11(11):761-74 [PMID: 21993244]
  10. J Clin Oncol. 1995 Aug;13(8):2123-39 [PMID: 7636557]
  11. J Natl Cancer Inst. 1969 Dec;43(6):1365-73 [PMID: 5396222]
  12. Cancer Lett. 2004 Feb 20;204(2):179-87 [PMID: 15013217]
  13. Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5349-54 [PMID: 24706870]
  14. Cancer Res. 2009 Apr 1;69(7):2902-11 [PMID: 19339268]
  15. Science. 2000 Mar 17;287(5460):1969-73 [PMID: 10720316]
  16. Int J Cancer. 2014 Oct 1;135(7):1543-52 [PMID: 24550147]
  17. Clin Cancer Res. 2012 May 15;18(10):2780-90 [PMID: 22589486]
  18. Cancer Cell. 2013 Dec 9;24(6):710-24 [PMID: 24332040]
  19. J Clin Oncol. 2012 Jan 20;30(3):308-15 [PMID: 22184391]
  20. Cancer. 2014 Aug 15;120(16):2448-56 [PMID: 24797726]
  21. J Clin Oncol. 2012 May 20;30(15):1822-8 [PMID: 22355053]
  22. Hum Genet. 1996 Feb;97(2):163-70 [PMID: 8566947]
  23. Nat Genet. 1993 Feb;3(2):113-7 [PMID: 8098985]
  24. PLoS One. 2013 Oct 04;8(10):e76551 [PMID: 24124571]
  25. J Clin Invest. 2014 Jan;124(1):30-9 [PMID: 24382387]
  26. J Clin Oncol. 2009 Nov 1;27(31):5182-8 [PMID: 19770373]
  27. Biochem Biophys Res Commun. 2008 Jan 18;365(3):568-74 [PMID: 18022385]
  28. Genes Chromosomes Cancer. 2011 Jun;50(6):397-408 [PMID: 21412928]
  29. J Clin Oncol. 2012 May 10;30(14):1670-7 [PMID: 22454413]
  30. Cancer Res. 2011 Oct 15;71(20):6300-9 [PMID: 21998010]
  31. Pediatr Blood Cancer. 2011 Apr;56(4):595-603 [PMID: 21298745]
  32. Pediatr Blood Cancer. 2012 Jul 15;59(1):5-10 [PMID: 22378628]
  33. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7480-4 [PMID: 2798419]
  34. Genes Chromosomes Cancer. 2002 Mar;33(3):310-21 [PMID: 11807989]
  35. Nat Med. 2001 Jun;7(6):673-9 [PMID: 11385503]
  36. J Clin Oncol. 2010 Jul 20;28(21):3525-30 [PMID: 20458041]
  37. Hum Mol Genet. 1995 Dec;4(12):2355-62 [PMID: 8634710]
  38. Curr Top Dev Biol. 2011;94:197-234 [PMID: 21295688]
  39. Clin Cancer Res. 2003 Nov 15;9(15):5749-55 [PMID: 14654560]
  40. Adv Anat Pathol. 2013 Nov;20(6):387-97 [PMID: 24113309]
  41. J Clin Oncol. 2012 Sep 10;30(26):3264-70 [PMID: 22869886]
  42. Cancer Genet Cytogenet. 2000 Feb;117(1):37-40 [PMID: 10700864]
  43. Clin Cancer Res. 2010 Mar 15;16(6):1894-903 [PMID: 20215554]
  44. J Clin Oncol. 1999 Nov;17(11):3487-93 [PMID: 10550146]
  45. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13264-9 [PMID: 10557309]
  46. Cancer Res. 1996 Jul 15;56(14):3220-4 [PMID: 8764111]
  47. Cancer Res. 1998 Oct 1;58(19):4426-33 [PMID: 9766674]
  48. Development. 2013 Jul;140(14):3040-50 [PMID: 23821038]
  49. Med Pediatr Oncol. 2000 Aug;35(2):96-103 [PMID: 10918230]
  50. Leuk Lymphoma. 2011 Jun;52 Suppl 2:82-6 [PMID: 21599609]
  51. Mod Pathol. 2000 Sep;13(9):988-93 [PMID: 11007039]
  52. Eur J Pediatr. 2000 Mar;159(3):139-42 [PMID: 10664222]
  53. Cancer Res. 2005 Oct 15;65(20):9226-35 [PMID: 16230383]
  54. J Natl Cancer Inst. 2011 Jun 22;103(12):962-78 [PMID: 21653923]
  55. J Clin Pathol. 2003 Jun;56(6):412-6 [PMID: 12783965]
  56. Cancer. 2009 Sep 15;115(18):4218-26 [PMID: 19536876]
  57. BMC Cancer. 2014 Feb 27;14:139 [PMID: 24575771]
  58. Cancer Res. 1989 Jul 1;49(13):3631-6 [PMID: 2471586]
  59. Cancer Res. 2004 Aug 15;64(16):5539-45 [PMID: 15313887]
  60. Am Soc Clin Oncol Educ Book. 2013;:420-4 [PMID: 23714564]
  61. Cell Cycle. 2012 Oct 15;11(20):3828-36 [PMID: 22983009]
  62. Cancer Res. 1995 May 1;55(9):1836-8 [PMID: 7728748]
  63. Front Oncol. 2012 Dec 17;2:194 [PMID: 23251904]
  64. Genes Chromosomes Cancer. 2007 Nov;46(11):1028-38 [PMID: 17696196]
  65. Genes Chromosomes Cancer. 2000 May;28(1):1-13 [PMID: 10738297]
  66. Clin Cancer Res. 2011 May 1;17(9):2613-8 [PMID: 21367748]
  67. J Pediatr. 2004 May;144(5):666-8 [PMID: 15127010]
  68. Mol Cancer Ther. 2006 May;5(5):1299-308 [PMID: 16731763]
  69. Cancer Discov. 2014 Feb;4(2):216-31 [PMID: 24436047]
  70. Clin Cancer Res. 2010 Dec 15;16(24):6132-8 [PMID: 21037025]
  71. J Clin Invest. 1994 Jul;94(1):445-8 [PMID: 8040287]
  72. Genes Chromosomes Cancer. 2009 Aug;48(8):661-72 [PMID: 19422036]
  73. Pediatr Blood Cancer. 2014 Mar;61(3):452-6 [PMID: 23956055]
  74. PLoS One. 2013;8(2):e58193 [PMID: 23469153]
  75. Carcinogenesis. 2006 Sep;27(9):1758-67 [PMID: 16537559]
  76. Cell. 2013 Mar 28;153(1):71-85 [PMID: 23540691]
  77. Cancer Res. 2013 May 15;73(10):3041-50 [PMID: 23536553]
  78. N Engl J Med. 2008 Aug 7;359(6):613-26 [PMID: 18687642]
  79. Cancer Res. 2006 May 1;66(9):4742-9 [PMID: 16651427]
  80. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13164-9 [PMID: 8917562]
  81. Am J Pathol. 1998 Apr;152(4):1071-9 [PMID: 9546368]
  82. Br J Cancer. 2009 Sep 1;101(5):774-81 [PMID: 19707204]
  83. J Mol Diagn. 2006 May;8(2):202-8 [PMID: 16645206]
  84. Cancer Res. 2010 Aug 15;70(16):6497-508 [PMID: 20663909]
  85. Nat Genet. 2014 Jun;46(6):595-600 [PMID: 24793135]
  86. Am J Hum Genet. 1989 May;44(5):720-3 [PMID: 2565083]
  87. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):237-45 [PMID: 20646843]
  88. Oncogene. 2010 Jul 8;29(27):3942-52 [PMID: 20453878]
  89. Cancer Res. 2005 Jun 1;65(11):4490-5 [PMID: 15930263]
  90. Cancer Cell. 2008 Nov 4;14(5):369-81 [PMID: 18977326]
  91. Cell Cycle. 2014;13(4):516-27 [PMID: 24496329]
  92. Genes Chromosomes Cancer. 2000 Apr;27(4):337-44 [PMID: 10719362]
  93. Clin Cancer Res. 2012 Feb 1;18(3):748-57 [PMID: 22142829]
  94. Clin Cancer Res. 2013 Nov 1;19(21):5940-51 [PMID: 23918606]
  95. Genes Dev. 2004 Nov 1;18(21):2614-26 [PMID: 15489287]
  96. Epigenetics. 2012 Apr;7(4):400-8 [PMID: 22419069]
  97. Annu Rev Cell Dev Biol. 2007;23:645-73 [PMID: 17506689]
  98. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9805-9 [PMID: 8790412]
  99. Int J Oncol. 1998 Jun;12(6):1299-306 [PMID: 9592190]
  100. Cancer Res. 2006 Jul 15;66(14):6936-46 [PMID: 16849537]
  101. Cancer Lett. 2013 Sep 1;337(2):200-9 [PMID: 23684925]
  102. Cancer Res. 1994 Jun 1;54(11):2869-72 [PMID: 8187070]
  103. J Pathol. 2014 Feb;232(3):300-7 [PMID: 24272621]
  104. Oncogene. 2006 Dec 14;25(59):7673-9 [PMID: 16785989]
  105. Cell Growth Differ. 1990 Jul;1(7):325-31 [PMID: 2177632]
  106. PLoS One. 2013;8(1):e55072 [PMID: 23372815]
  107. Pediatr Blood Cancer. 2013 Sep;60(9):1411-7 [PMID: 23526739]

Grants

  1. ZIA BC010998-09/Intramural NIH HHS

MeSH Term

Animals
Child
Epigenomics
Humans
Molecular Targeted Therapy
Rhabdomyosarcoma
Sarcoma

Word Cloud

Created with Highcharts 10.0.0Rhabdomyosarcomadiseasecommonsoft-tissuesarcomachildhooddespiteclinicaladvancessubsetspatientscontinuesufferhighlevelsmorbiditymortalityassociatedRecentgeneticmolecularcharacterizationtumorsusingsophisticatedgenomicstechniquesincludingnext-generationsequencingexperimentsrevealedmultipleareascanexploitednewmolecularlytargetedtherapiesPediatric

Similar Articles

Cited By